Language

English

Publication Date

5-1-2026

Journal

Journal of the Pediatric Orthopaedic Society of North America

DOI

10.1016/j.jposna.2026.100370

PMID

42079783

PMCID

PMC13134026

PubMedCentral® Posted Date

3-20-2026

PubMedCentral® Full Text Version

Post-print

Abstract

Background: While obesity is a well-established risk factor for slipped capital femoral epiphysis (SCFE), limited data exist regarding its impact on postoperative complication rates. This study aimed to evaluate the association between obesity and complications following SCFE treatment.

Methods: We queried a large national database for pediatric patients who underwent treatment for SCFE between June 2005 and June 2025. We divided this cohort into patients with obesity and patients without obesity. We matched the cohorts with a propensity scoring algorithm on a one-to-one basis, resulting in 1,175 patients in each group. We tracked outcomes including infection, pulmonary embolism (PE), chondrolysis, avascular necrosis (AVN), leg length discrepancy (LLD), and hardware complications. We used the relative risk ratio (RR) and 95% confidence intervals (CIs). P values less than 0.05 were considered significant.

Results: ≤10 (0.85%) patients developed an infection, and none developed a PE; ≤10 (0.85%) patients in each group developed chondrolysis. Thirty-eight (3.23%) patients in the obese group developed AVN after SCFE treatment, and 34 (2.89%) patients in the nonobese group developed AVN (RR = 1.12, CI: 0.71-1.76, P = .632). Seventy-seven (6.55%) patients in the obese group developed LLD compared to 50 (4.26%) patients in the nonobese group (RR = 1.54, CI: 1.09-2.18, P = .014). Sixty-one (5.19%) patients in the obese group had hardware complications, whereas 35 (2.98%) patients in the nonobese group had hardware complications (RR = 1.74, CI: 1.16-2.62, P = .007).

Conclusions: Patients with obesity had increased rates of LLD and hardware complications after treatment for SCFE compared to nonobese patients. Our findings highlight the importance of ongoing follow-up and monitoring of SCFE patients to detect the development of any of these outcomes.

Key concepts: (1)Rates of infection, pulmonary embolism, and chondrolysis were low (< 1%) and did not differ between obese and nonobese cohorts.(2)The rate of avascular necrosis was similar between groups.(3)In contrast, obese patients had significantly higher rates of leg length discrepancy and hardware complications.

Level of evidence: III: Retrospective cohort study.

Keywords

Slipped capital femoral epiphysis, Complications, Obesity, Avascular necrosis

Published Open-Access

yes

Download

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.